New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Support.com, Inc (NASDAQ:SPRT), Verso Paper Corp (NYSE:VRS), BG Medicine, Inc (NASDAQ:BGMD), Pacific Biosciences of California (NASDAQ:PACB)
Support.com, Inc (NASDAQ:SPRT) showed a volume of 1.24 million shares by the end of last trade whereas the average volume of the stock remained 566,529.00 shares. The stock opened the session at $2.92 but then moved to $3.03. At that price, the stock showed a positive performance of 6.32%. Support.com, Inc. (Support.com) provides cloud-based services and software that power technology support programs and technical support organizations. The Company’s technology support programs help brands create new revenue streams and customer relationships.
Will SPRT Continue To Move Higher? Find Out Here
Verso Paper Corp (NYSE:VRS) opened the session at $3.25 and closed the session at $3.13. Traded with volume of 1.23 million shares in the prior session and the average volume of the stock remained 930,025.00 shares. Verso Paper Corp. (Verso Paper) is a holding company. Verso Paper is engaged in producer of coated freesheet, coated groundwood, and uncoated supercalendered papers. These products are used in catalogs, magazines, retail inserts, and commercial print.
Is VRS a Solid Investment at These Levels? Read This Report For Details
BG Medicine, Inc (NASDAQ:BGMD) opened the session at $1.38 and closed the session at $1.28. The stock showed a negative performance of -6.57% in previous trading session. Traded with volume of 1.22 million shares in the prior session and the average volume of the stock remained 3.21 million shares. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests.
Why Should Investors Buy BGMD After the Recent Fall? Just Go Here and Find Out
Pacific Biosciences of California (NASDAQ:PACB) the stock decreased -5.02% and finished the session at $5.68. Traded with volume of 1.20 million shares in the prior session and the average volume of the stock remained 678,548.00 shares. The beta of the stock remained 3.14. Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States.
Will PACB Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)